Qilian International Holding Group Limited (NASDAQ:QLI) Sees Large Growth in Short Interest

Qilian International Holding Group Limited (NASDAQ:QLI) was the target of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 63,200 shares, an increase of 971.2% from the March 31st total of 5,900 shares. Currently, 0.8% of the company’s stock are short sold. Based on an average daily volume of 161,000 shares, the days-to-cover ratio is presently 0.4 days.

Qilian International Holding Group Stock Performance

Shares of Qilian International Holding Group stock traded down $0.01 during midday trading on Thursday, hitting $0.78. The company had a trading volume of 1,940 shares, compared to its average volume of 136,359. Qilian International Holding Group has a 52-week low of $0.36 and a 52-week high of $1.30. The company has a 50 day moving average of $0.64 and a 200 day moving average of $0.57.

Qilian International Holding Group Company Profile

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.